{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:22:26Z","timestamp":1789791746623,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1124\/mol.105.012716","type":"journal-article","created":{"date-parts":[[2005,8,27]],"date-time":"2005-08-27T00:33:34Z","timestamp":1125102814000},"page":"1636-1644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival"],"prefix":"10.1016","volume":"68","author":[{"given":"Larry M.","family":"Karnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Flatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Loegering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Hackbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonnet J.H.","family":"Arlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Vroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Bijoy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Un","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard B.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Cliby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott H.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.012716_bib1","doi-asserted-by":"crossref","first-page":"52572","DOI":"10.1074\/jbc.M309054200","article-title":"Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress","volume":"278","author":"Arlander","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)80086-0","article-title":"ATM-deficient mice: a paradigm of ataxia telangiectasia","volume":"86","author":"Barlow","year":"1996","journal-title":"Cell"},{"key":"10.1124\/mol.105.012716_bib3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1073\/pnas.0437927100","article-title":"Loading of the human 9-1-1 checkpoint complex onto DNA by the checkpoint clamp loader hRad17-replication factor C complex in vitro","volume":"100","author":"Bermudez","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.012716_bib4","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1016\/S0021-9258(18)66672-4","article-title":"Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis","volume":"261","author":"Bianchi","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib5","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1093\/hmg\/ddh316","article-title":"ATM is required for the cellular response to thymidine induced replication fork stress","volume":"13","author":"Bolderson","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1124\/mol.105.012716_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jcp.54.7.512","article-title":"Ataxia telangiectasia gene mutations in leukaemia and lymphoma","volume":"54","author":"Boultwood","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1124\/mol.105.012716_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1101\/gad.14.4.397","article-title":"ATR disruption leads to chromosomal fragmentation and early embryonic death","volume":"14","author":"Brown","year":"2000","journal-title":"Genes Dev"},{"key":"10.1124\/mol.105.012716_bib8","doi-asserted-by":"crossref","first-page":"42462","DOI":"10.1074\/jbc.C100466200","article-title":"ATM phosphorylates histone H2AX in response to DNA double-strand breaks","volume":"276","author":"Burma","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib9","doi-asserted-by":"crossref","first-page":"26343","DOI":"10.1074\/jbc.M001244200","article-title":"Retention of the hRad9 checkpoint complex in extraction-resistant nuclear complexes after DNA damage","volume":"275","author":"Burtelow","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib10","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/sj.onc.1207394","article-title":"Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis","volume":"23","author":"Busino","year":"2004","journal-title":"Oncogene"},{"issue":"Suppl 3","key":"10.1124\/mol.105.012716_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1998.750","article-title":"The role of gemcitabine in the treatment of other tumours","volume":"78","author":"Carmichael","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.105.012716_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0092-8674(02)01113-3","article-title":"ATR regulates fragile site stability","volume":"111","author":"Casper","year":"2002","journal-title":"Cell"},{"key":"10.1124\/mol.105.012716_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/cc.4.1.1299","article-title":"Chk1 is essential for tumor cell viability following activation of the replication checkpoint","volume":"4","author":"Cho","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1124\/mol.105.012716_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/emboj\/17.1.159","article-title":"Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints","volume":"17","author":"Cliby","year":"1998","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.105.012716_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.2001.02795.x","article-title":"Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin\u2019s lymphoma","volume":"113","author":"Dumontet","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1124\/mol.105.012716_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.012716_bib17","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1128\/MCB.24.16.7235-7248.2004","article-title":"Deletion of mouse rad9 causes abnormal cellular responses to DNA damage, genomic instability and embryonic lethality","volume":"24","author":"Hopkins","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.105.012716_bib18","doi-asserted-by":"crossref","first-page":"20475","DOI":"10.1074\/jbc.M213159200","article-title":"The Chk2 tumor suppressor is not required for p53 responses in human cancer cells","volume":"278","author":"Jallepalli","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/bj20031119","article-title":"Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition","volume":"375","author":"Komander","year":"2003","journal-title":"Biochem J"},{"key":"10.1124\/mol.105.012716_bib20","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1101\/gad.14.12.1448","article-title":"Chk1 is an essential kinase that is regulated by ATR and required for the G2\/M DNA damage checkpoint","volume":"14","author":"Liu","year":"2000","journal-title":"Genes Dev"},{"key":"10.1124\/mol.105.012716_bib21","doi-asserted-by":"crossref","first-page":"18641","DOI":"10.1074\/jbc.M313536200","article-title":"Rad9 protects cells from topoisomerase poison-induced cell death","volume":"279","author":"Loegering","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1182\/blood-2004-09-3523","article-title":"Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine","volume":"106","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"10.1124\/mol.105.012716_bib23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00001622-200111000-00015","article-title":"Gemcitabine in hematologic malignancies","volume":"13","author":"Nabhan","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1124\/mol.105.012716_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jcs.01626","article-title":"G2 damage checkpoints: what is the turn-on?","volume":"118","author":"O\u2019Connell","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1124\/mol.105.012716_bib25","first-page":"3","article-title":"Gemcitabine: Preclinical Pharmacology and Mechanisms of Action","volume":"23","author":"Plunkett","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1124\/mol.105.012716_bib26","doi-asserted-by":"crossref","first-page":"24428","DOI":"10.1074\/jbc.M301544200","article-title":"Phosphorylation of human Rad9 is required for genotoxin-activated checkpoint signaling","volume":"278","author":"Roos-Mattjus","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib27","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1038\/sj.onc.1207229","article-title":"Mechanisms of apoptosis induction by nucleoside analogs","volume":"22","author":"Sampath","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.105.012716_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1023\/A:1008307528519","article-title":"Gemcitabine for relapsed or resistant lymphoma","volume":"11","author":"Savage","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1124\/mol.105.012716_bib29","first-page":"756","article-title":"Abrogation of Chk1-mediated S\/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells","volume":"25","author":"Shao","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1124\/mol.105.012716_bib30","first-page":"1065","article-title":"S-Phase arrest by nucleoside analogues and abrogation of survival without cell cycle progression by 7-hydroxystaurosporine","volume":"61","author":"Shi","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/mol.105.012716_bib31","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1093\/emboj\/cdf506","article-title":"Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription","volume":"21","author":"Takai","year":"2002","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.105.012716_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1074\/jbc.274.2.567","article-title":"Human homologs of Schizosaccharomyces pombe Rad1, Hus1 and Rad9 form a DNA damage-responsive protein complex","volume":"274","author":"Volkmer","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib33","doi-asserted-by":"crossref","first-page":"26136","DOI":"10.1074\/jbc.M200357200","article-title":"Mismatch repair in human nuclear extracts. Quantitative analyses of excision of nicked circular mismatched DNA substrates, constructed by a new technique employing synthetic oligonucleotides","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1124\/mol.52.6.1000","article-title":"Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-\u03b2-d-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2","volume":"52","author":"Wang","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.012716_bib35","doi-asserted-by":"crossref","first-page":"47759","DOI":"10.1074\/jbc.C100569200","article-title":"Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress","volume":"276","author":"Ward","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.012716_bib36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0145-2126(00)00106-5","article-title":"Gemcitabine demonstrates in vitro activity against human B-cell chronic lymphocytic leukemia","volume":"25","author":"Waselenko","year":"2001","journal-title":"Leuk Res"},{"key":"10.1124\/mol.105.012716_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2003.12.005","article-title":"Altered states: selectively drugging the Hsp90 cancer chaperone","volume":"10","author":"Workman","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1124\/mol.105.012716_bib38","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/MCB.21.13.4129-4139.2001","article-title":"ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1","volume":"21","author":"Zhao","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.105.012716_bib39","doi-asserted-by":"crossref","first-page":"14795","DOI":"10.1073\/pnas.182557299","article-title":"Disruption of the checkpoint kinase 1\/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints","volume":"99","author":"Zhao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.105.012716_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1101\/gad.950302","article-title":"Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin","volume":"16","author":"Zou","year":"2002","journal-title":"Genes Dev"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24065611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24065611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.012716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T09:00:36Z","timestamp":1740042036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24065611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0026895X24065611"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.012716","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.012716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}